Encompassing 90–95% of all global diabetes cases, T2DM is characterized by the impaired secretion of insulin from beta cells in the pancreas, along with reduced insulin sensitivity in peripheral tissues, such as skeletal muscle, liver, and adipose tissue [24,25]. This evidence concerns the gene INS and diabetes mellitus.